Ingevity Co. (NYSE:NGVT) Shares Sold by Leeward Investments LLC MA

Leeward Investments LLC MA reduced its position in Ingevity Co. (NYSE:NGVT - Free Report) by 14.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 175,363 shares of the company's stock after selling 29,243 shares during the period. Leeward Investments LLC MA owned about 0.48% of Ingevity worth $6,839,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the business. First Horizon Advisors Inc. increased its holdings in shares of Ingevity by 809.2% in the second quarter. First Horizon Advisors Inc. now owns 591 shares of the company's stock valued at $26,000 after purchasing an additional 526 shares during the last quarter. Blue Trust Inc. increased its stake in Ingevity by 101.8% during the second quarter. Blue Trust Inc. now owns 896 shares of the company's stock worth $43,000 after purchasing an additional 452 shares during the period. Headlands Technologies LLC purchased a new position in shares of Ingevity in the second quarter valued at approximately $46,000. nVerses Capital LLC acquired a new position in shares of Ingevity in the third quarter valued at approximately $113,000. Finally, Nisa Investment Advisors LLC lifted its holdings in Ingevity by 27.3% during the 3rd quarter. Nisa Investment Advisors LLC now owns 3,880 shares of the company's stock worth $151,000 after buying an additional 831 shares in the last quarter. Hedge funds and other institutional investors own 91.59% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on NGVT shares. CJS Securities raised Ingevity from a "market perform" rating to an "outperform" rating and set a $58.00 price objective on the stock in a research report on Wednesday, August 7th. Wells Fargo & Company decreased their price objective on Ingevity from $45.00 to $40.00 and set an "equal weight" rating for the company in a research note on Monday, August 5th. BMO Capital Markets upped their target price on shares of Ingevity from $40.00 to $47.00 and gave the stock a "market perform" rating in a research note on Thursday, October 31st. Finally, Oppenheimer decreased their price target on shares of Ingevity from $58.00 to $50.00 and set an "outperform" rating for the company in a research note on Thursday, August 1st. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, Ingevity presently has a consensus rating of "Moderate Buy" and a consensus target price of $52.17.

Ingevity Stock Down 1.6 %

NGVT stock traded down $0.75 during midday trading on Friday, reaching $45.50. 118,934 shares of the company were exchanged, compared to its average volume of 267,402. The company has a debt-to-equity ratio of 6.52, a quick ratio of 1.04 and a current ratio of 1.76. The stock's 50-day simple moving average is $37.36 and its 200 day simple moving average is $42.42. The company has a market cap of $1.65 billion, a price-to-earnings ratio of -2.98 and a beta of 1.60. Ingevity Co. has a 1-year low of $30.90 and a 1-year high of $56.29.

Ingevity (NYSE:NGVT - Get Free Report) last announced its earnings results on Tuesday, October 29th. The company reported $1.10 EPS for the quarter, beating analysts' consensus estimates of $0.60 by $0.50. The business had revenue of $376.90 million for the quarter, compared to analysts' expectations of $376.95 million. Ingevity had a negative net margin of 38.11% and a positive return on equity of 24.46%. The company's quarterly revenue was down 15.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.21 EPS. On average, equities analysts forecast that Ingevity Co. will post 2.55 earnings per share for the current year.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.